JUNE 2016 TABLE OF CONTENTS INTRODUCTION

First Page		Document Content
Date: 2016-07-15 09:12:19 Monoclonal antibodies Immunosuppressants Biotechnology Immunology Autoimmune diseases Infliximab TNF inhibitor Adalimumab Biopharmaceutical Monoclonal antibody therapy Etanercept Ulcerative colitis		JUNE 2016 TABLE OF CONTENTS INTRODUCTION Add to Reading List Source URL: www.abirisk.eu Download Document from Source Website File Size: 1,30 MB Share Document on Facebook

	Biotechnology, BS "DBEFNJD.BQ 5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT DocID: 1xTqy - View Document
	PDF Document DocID: 1wroO - View Document
	Building A Better Mousetrap: Patenting Biotechnology In The European Community DocID: 1vr7C - View Document
	BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod DocID: 1vq6b - View Document
	Biotechnology Consultation Agency Response Letter BNF DocID: 1vpUZ - View Document